SYNOCURE® 886 S 70

GENERAL INDUSTRY ARKEMA COATING RESINS

SYNOCURE® 886 S 70 is an acid functional acrylic resin designed to crosslink at room temperature
with epoxy resins to give high solids content isocyanate-free two-pack coating systems.
Product Coatings based on this resin are especially suitable for protection and maintenance in areas where
Application details rapid drying, hardness and abrasion resistance are required.
SYNOCURE® 886 S 70 has been designed to react with economic bisphenol A type epoxies and
still maintain good exterior durability.

• Coatings formulation with VOC at or below 420g/l at application viscosity

Performance
• Fast drying
Benefits • Good exterior durability

Polymer
• Solventborne Acrylic
Type

Solid Content at 125°C, % (ISO 3251) 68 - 72

Sales Viscosity at 25°C, mPa.s (ISO 3219) 3000 - 6000
Specifications Colour, Gardner scale (ISO 4630) 5 max
Acid value, mg KOH/g (ISO 2114) 44 - 52

Volatile 2:1 xylene : n-butanol

Flash point, °C (ISO 3679) 24
Other Density / Specific Gravity at 20°C, g/ml (ISO 2811) 1.01
Characteristics1 Note: Acid value and/or Hydroxyl value quoted relative to solid resin

1 The data provided for these properties are typical values, intended only as guides, and should not be construed as sales specifications

RECOMMENDATIONS FOR USE

SYNOCURE® 886 S 70 is designed for use with low viscosity epoxy resins of epoxy equivalent
weight 180-190 (1)
Active hydrogen equivalent weight of SYNOCURE® 886 S 70 is 1145 based on solid resin. A
stoichiometric mixing ratio of 1/1 to 1.25 / 1 epoxy / active hydrogen equivalents is recommended
although minor deviations from this will have little effect on performance.
This isocyanate-free system is suitable for use with a wide range of both organic and inorganic
pigments. As with other reactive two-component systems it is strongly recommended that all
pigments are checked for stability with the system before commercialisation.
Formulation SOLUBILITY
Guidelines Aromatic hydrocarbons such as xylene together with minor proportions of esters and alcohols are
the most suitable.
OTHER ADDITIVES
Hindered amine light stabilisers (HALS) (2) are strongly recommended as additives for these
acrylic/epoxy systems.
SYNOCURE® 886 S 70 should only be used in applications consistent with the above
recommendations. Proposals to use the resin in alternative systems should be discussed with
Arkema before any action is taken.

Notes: (1) Araldite® GY250 (Hunstman) or Epikote™ Resin 828 (Momentive), (2) Tinuvin® 292 (Ciba) at 2% (based on
total resin solids)
Product
Please refer to the corresponding Safety Data Sheet.
Safety

SYNOCURE® 886 S 70 should be stored indoors in the original, unopened and undamaged
Storage &
container, in a dry place at a temperature not exceeding 30°C. Exposure to direct sunlight should
Handling be avoided.
In the above mentioned storage conditions the shelf life of the resin will be 12 months from the
shipping date

Arkema France - A French "société anonyme", registered with the Commercial and Companies Register of Nanterre (France) under number 319 632 790

The statements, technical information and recommendations contained herein are believed to be accurate as of the date hereof. Since the conditions and methods of use of the product and of the
information referred to herein are beyond our control, Arkema expressly disclaims any and all liability as to any results obtained or arising from any use of the product or reliance on such information; NO
WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE GOODS DESCRIBED OR
THE INFORMATION PROVIDED HEREIN. The information provided herein relates only to the specific product designated and may not be applicable when such product is used in combination with other
materials or in any process. The user should thoroughly test any application before commercialization. Nothing contained herein constitutes a license to practice under any patent and it should not be
construed as an inducement to infringe any patent and the user is advised to take appropriate steps to be sure that any proposed use of the product will not result in patent infringement. See SDS for
Health & Safety Considerations.
Arkema has implemented a Medical Policy regarding the use of Arkema products in medical devices applications that are in contact with the body or circulating bodily fluids
(http://www.arkema.com/en/social-responsibility/responsible-product-management/medical-device-policy/index.html) Arkema has designated medical grades to be used for such medical device
applications. Products that have not been designated as medical grades are not authorized by Arkema for use in medical device applications that are in contact with the body or circulating bodily fluids. In
addition, Arkema strictly prohibits the use of any Arkema products in medical device applications that are implanted in the body or in contact with bodily fluids or tissues for greater than 30 days. The
Arkema trademarks and the Arkema name shall not be used in conjunction with customers’ medical devices, including without limitation, permanent or temporary implantable devices, and customers shall
not represent to anyone else, that Arkema allows, endorses or permits the use of Arkema products in such medical devices.
It is the sole responsibility of the manufacturer of the medical device to determine the suitability (including biocompatibility) of all raw materials, products and components, including any medical grade
- 07/2022

Arkema products, in order to ensure that the final end-use product is safe for its end use; performs or functions as intended; and complies with all applicable legal and regulatory requirements (FDA or
other national drug agencies). It is the sole responsibility of the manufacturer of the medical device to conduct all necessary tests and inspections and to evaluate the medical device under actual end-use
requirements and to adequately advise and warn purchasers, users, and/or learned intermediaries (such as physicians) of pertinent risks and fulfill any postmarket surveillance obligations. Any decision
regarding the appropriateness of a particular Arkema material in a particular medical device should be based on the judgment of the manufacturer, seller, the competent authority, and the treating physician.

Arkema Coating Resins

420, rue d’Estienne d’Orves
92705 Colombes Cedex - France
arkema.com - arkemacoatingresins.com